Seroprevalence of SARS-CoV-2 antibodies and reduced risk of reinfection through 6 months: a Danish observational cohort study of 44 000 healthcare workers

OBJECTIVES: Antibodies to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) are a key factor in protecting against coronavirus disease 2019 (COVID-19). We examined longitudinal changes in seroprevalence in healthcare workers (HCWs) in Copenhagen and the protective effect of antibodies aga...

Descripción completa

Detalles Bibliográficos
Autores principales: Iversen, Kasper, Kristensen, Jonas Henrik, Hasselbalch, Rasmus Bo, Pries-Heje, Mia, Nielsen, Pernille Brok, Knudsen, Andreas Dehlbæk, Fogh, Kamille, Norsk, Jakob Boesgaard, Andersen, Ove, Fischer, Thea Køhler, Juul Jensen, Claus Antonio, Torp-Pedersen, Christian, Rungby, Jørgen, Ditlev, Sisse Bolm, Hageman, Ida, Møgelvang, Rasmus, Gybel-Brask, Mikkel, Dessau, Ram B., Sørensen, Erik, Harritshøj, Lene, Folke, Fredrik, Sten, Curt, Engel Møller, Maria Elizabeth, Benfield, Thomas, Ullum, Henrik, Jørgensen, Charlotte Sværke, Erikstrup, Christian, Ostrowski, Sisse R., Nielsen, Susanne Dam, Bundgaard, Henning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8447554/
https://www.ncbi.nlm.nih.gov/pubmed/34543759
http://dx.doi.org/10.1016/j.cmi.2021.09.005

Ejemplares similares

Ejemplares similares